Investigating the safety and efficacy of naltrexone for anti-psychotic induced weight gain in severe mental illness: study protocol of a double-blind, randomized, placebo-controlled trial

Lignende værker

• A Randomized, Double-Blind, Placebo-Controlled Pilot Study of Naltrexone to Counteract Antipsychotic-Associated Weight Gain: Proof of Concept
  af: Tek, Cenk, et al.
  Udgivet: (2014)
• The impact of eszopiclone on sleep and cognition in patients with schizophrenia and insomnia: A double-blind, randomized, placebo-controlled trial
  af: Tek, Cenk, et al.
  Udgivet: (2014)
• Antipsychotic-induced weight gain in first-episode psychosis patients: a meta-analysis of differential effects of antipsychotic medications
  af: Tek, Cenk, et al.
  Udgivet: (2015)
• Antipsychotic-Induced Weight Gain in First-Episode Psychosis Patients: A Meta-Analysis of Differential Effects of Antipsychotic Medications
  af: Tek, Cenk, et al.
  Udgivet: (2016)
• Obese schizophrenia spectrum patients have significantly higher 10-year general cardiovascular risk and vascular ages than obese individuals without severe mental illness
  af: Ratliff, Joseph C., et al.
  Udgivet: (2012)